Literature DB >> 1651427

Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment.

S Keay1, B Baldwin.   

Abstract

Human cytomegalovirus (CMV) infects cells by sequential processes involving attachment, fusion with the cell membrane, and penetration of the capsid. We used two monoclonal anti-idiotype that mimic one of the CMV envelope glycoproteins, gp86, to study its role in the early phases of CMV infection. Neither of two such antibodies inhibited virus binding to human embryonic lung (HEL) fibroblasts; however, both antibodies inhibited the fusion of CMV with HEL cells, as measured by an assay in which viral envelope is labeled with a fluorescent amphiphile (octadecyl rhodamine B chloride, or R18), resulting in increased fluorescence during fusion of virus with the cell membrane. Because these anti-idiotype antibodies were shown previously to bind to specific receptors on HEL cell membranes, these findings suggest that both gp86 and its cell membrane receptor may function in the fusion of human CMV with HEL cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651427      PMCID: PMC248982     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).

Authors:  G R Nemerow; R Wolfert; M E McNaughton; N R Cooper
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate.

Authors:  D WuDunn; P G Spear
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.

Authors:  G R Nemerow; C Mold; V K Schwend; V Tollefson; N R Cooper
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Preparation of Fab fragments from a mouse monoclonal IgM.

Authors:  J M Bidlack; P C Mabie
Journal:  J Immunol Methods       Date:  1986-07-24       Impact factor: 2.303

6.  A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus.

Authors:  N Miller; L M Hutt-Fletcher
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

Review 7.  The use of fluorescence dequenching measurements to follow viral membrane fusion events.

Authors:  A Loyter; V Citovsky; R Blumenthal
Journal:  Methods Biochem Anal       Date:  1988

8.  Transformation of a human poliovirus receptor gene into mouse cells.

Authors:  C Mendelsohn; B Johnson; K A Lionetti; P Nobis; E Wimmer; V R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  Mass action analysis of kinetics and extent of fusion between Sendai virus and phospholipid vesicles.

Authors:  S Nir; K Klappe; D Hoekstra
Journal:  Biochemistry       Date:  1986-12-16       Impact factor: 3.162

10.  Antiviral activity of carbobenzosy di- and tripeptides on measles virus.

Authors:  F A Miller; G J Dixon; G Arnett; J R Dice; W A Rightsel; F M Schabel; I W McLean
Journal:  Appl Microbiol       Date:  1968-10
View more
  27 in total

1.  Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.

Authors:  Regan N Theiler; Teresa Compton
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  The human fibroblast receptor for gp86 of human cytomegalovirus is a phosphorylated glycoprotein.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus.

Authors:  James R Netterwald; Thomas R Jones; William J Britt; Shao-Jun Yang; Ian P McCrone; Hua Zhu
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 6.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.

Authors:  A D Yurochko; E S Hwang; L Rasmussen; S Keay; L Pereira; E S Huang
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.

Authors:  M T Huber; T Compton
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.

Authors:  C Söderberg; S Larsson; S Bergstedt-Lindqvist; E Möller
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  CD13 (human aminopeptidase N) mediates human cytomegalovirus infection.

Authors:  C Söderberg; T D Giugni; J A Zaia; S Larsson; J M Wahlberg; E Möller
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.